November 16, 2021
The use of psychedelics like LSD, psilocybin, mescaline and DMT is associated with a significant decrease in illicit opioid consumption, according to a new study. Researchers looked at data from “three harmonized prospective cohorts of community-recruited” people with substance misuse disorders. A total of 3,813 individuals were involved... “Recent psychedelic use was associated with 55% reduced odds of daily opioid use,”...
Full articleNovember 4, 2021
Detroit voters decriminalized therapeutic mushrooms – also known as psychedelic or "magic" mushrooms. On Election Day Tuesday, voters were asked to vote on Proposal E, which would make "the personal possession and therapeutic use of entheogenic plants by adults the city's lowest law-enforcement priority." The measure passed with 61.08% of the vote.
Full articleOctober 26, 2021
One of the leading companies racing to develop psychedelics as legal medicines was granted a patent last week for a formulation of psilocybin — the hallucinogenic compound found in magic mushrooms — a decision that highlights the increasingly intense battle around intellectual property for potential medicines in this rapidly growing sector.
Full articleOctober 21, 2021
The City Council of Easthampton, Massachusetts voted on Wednesday, October 20, 2021, to end arrests for the growing of entheogenic plants and fungi, as well as to decriminalize the possession of most controlled substances.
Full articleOctober 21, 2021
With top medical research institutions now giving regular and serious consideration to the medical utility of psychedelics, the federal government is finally putting some money behind the movement. Baltimore’s Johns Hopkins Medicine announced Monday that the National Institutes of Health will provide nearly $4 million to help researchers study how psilocybin can affect tobacco addiction.
Full article